STOCK TITAN

[8-K] HCA Healthcare, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

HCA Healthcare, Inc. reported that it issued a press release covering its results for the third quarter ended September 30, 2025, and declared a quarterly cash dividend.

The Board approved a $0.72 per-share dividend on common stock, payable on December 29, 2025 to shareholders of record at the close of business on December 15, 2025. The Q3 results press release is included as Exhibit 99.1.

HCA Healthcare, Inc. ha annunciato di aver emesso un comunicato stampa relativo ai suoi risultati del terzo trimestre chiuso al 30 settembre 2025, e ha dichiarato un dividendo trimestrale in contanti.

Il Consiglio ha approvato un dividendo di $0.72 per azione sulle azioni ordinarie, pagabile il 29 dicembre 2025 agli azionisti registrati alla chiusura delle contrattazioni del 15 dicembre 2025. Il comunicato sui risultati del Q3 è incluso come Esibizione 99.1.

HCA Healthcare, Inc. informó que emitió un comunicado de prensa que cubre sus resultados del tercer trimestre terminado el 30 de septiembre de 2025, y declaró un dividendo en efectivo trimestral.

La Junta aprobó un dividendo de $0.72 por acción en acciones comunes, pagadero el 29 de diciembre de 2025 a los accionistas registrados al cierre de operaciones del 15 de diciembre de 2025. El comunicado de resultados del Q3 se incluye como Anexo 99.1.

HCA Healthcare, Inc.는 2025년 9월 30일 종료된 3분기 실적에 대한 보도자료를 발행했고 분기 현금 배당을 선언했다고 발표했습니다.

이사회는 보통주에 대해 주당 $0.72의 배당금을, 주주권리확정일인 2025년 12월 15일 종가 기준으로 기록된 주주들에게 2025년 12월 29일에 지급하기로 승인했습니다. Q3 실적 보도자료는 부록 99.1로 포함되어 있습니다.

HCA Healthcare, Inc. a annoncé avoir publié un communiqué de presse couvrant ses résultats du troisième trimestre clos le 30 septembre 2025, et a déclaré un dividende trimestriel en espèces.

Le Conseil a approuvé un dividende de $0,72 par action sur les actions ordinaires, payable le 29 décembre 2025 aux actionnaires inscrits à la clôture des activités le 15 décembre 2025. Le communiqué sur les résultats du T3 est inclus en tant qu’Exhibit 99.1.

HCA Healthcare, Inc. gab bekannt, dass eine Pressemitteilung zu den Ergebnissen des dritten Quartals zum 30. September 2025 veröffentlicht wurde, und kündigte eine vierteljährliche Bardividende an.

Der Aufsichtsrat stimmte einer $0,72 pro Aktie Dividende auf Stammaktien zu, zahlbar am 29. Dezember 2025 an die am Ende des Handelstages am 15. Dezember 2025 eingetragenen Aktionäre. Die Q3-Ergebnissen Pressemitteilung ist als Exhibit 99.1 enthalten.

HCA Healthcare, Inc. أعلنت أنَّها أصدرت بياناً صحفياً يغطي نتائجها للربع الثالث المنتهي في 30 سبتمبر 2025، وأعلنت عن توزيع نقدي ربعي.

وافق المجلس على توزيعة قدرها $0.72 للسهم على الأسهم العادية، القابلة للدفع في 29 ديسمبر 2025 للمساهمين المسجلين حتى إغلاق جلسة العمل في 15 ديسمبر 2025. كما أن بيان نتائج الربع الثالث مرفق ك Exhibit 99.1.

HCA Healthcare, Inc. 发布了一份新闻稿,涵盖截至2025年9月30日的第三季度业绩,并宣布季度现金分红。

董事会批准对普通股的每股分红为 $0.72,于2025年12月29日支付,登记在册的股东为在2025年12月15日收盘时的股东。第三季度业绩新闻稿包含在展品 99.1 中。

Positive
  • None.
Negative
  • None.

HCA Healthcare, Inc. ha annunciato di aver emesso un comunicato stampa relativo ai suoi risultati del terzo trimestre chiuso al 30 settembre 2025, e ha dichiarato un dividendo trimestrale in contanti.

Il Consiglio ha approvato un dividendo di $0.72 per azione sulle azioni ordinarie, pagabile il 29 dicembre 2025 agli azionisti registrati alla chiusura delle contrattazioni del 15 dicembre 2025. Il comunicato sui risultati del Q3 è incluso come Esibizione 99.1.

HCA Healthcare, Inc. informó que emitió un comunicado de prensa que cubre sus resultados del tercer trimestre terminado el 30 de septiembre de 2025, y declaró un dividendo en efectivo trimestral.

La Junta aprobó un dividendo de $0.72 por acción en acciones comunes, pagadero el 29 de diciembre de 2025 a los accionistas registrados al cierre de operaciones del 15 de diciembre de 2025. El comunicado de resultados del Q3 se incluye como Anexo 99.1.

HCA Healthcare, Inc.는 2025년 9월 30일 종료된 3분기 실적에 대한 보도자료를 발행했고 분기 현금 배당을 선언했다고 발표했습니다.

이사회는 보통주에 대해 주당 $0.72의 배당금을, 주주권리확정일인 2025년 12월 15일 종가 기준으로 기록된 주주들에게 2025년 12월 29일에 지급하기로 승인했습니다. Q3 실적 보도자료는 부록 99.1로 포함되어 있습니다.

HCA Healthcare, Inc. a annoncé avoir publié un communiqué de presse couvrant ses résultats du troisième trimestre clos le 30 septembre 2025, et a déclaré un dividende trimestriel en espèces.

Le Conseil a approuvé un dividende de $0,72 par action sur les actions ordinaires, payable le 29 décembre 2025 aux actionnaires inscrits à la clôture des activités le 15 décembre 2025. Le communiqué sur les résultats du T3 est inclus en tant qu’Exhibit 99.1.

HCA Healthcare, Inc. gab bekannt, dass eine Pressemitteilung zu den Ergebnissen des dritten Quartals zum 30. September 2025 veröffentlicht wurde, und kündigte eine vierteljährliche Bardividende an.

Der Aufsichtsrat stimmte einer $0,72 pro Aktie Dividende auf Stammaktien zu, zahlbar am 29. Dezember 2025 an die am Ende des Handelstages am 15. Dezember 2025 eingetragenen Aktionäre. Die Q3-Ergebnissen Pressemitteilung ist als Exhibit 99.1 enthalten.

false000086073000008607302025-10-242025-10-24

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 24, 2025

 

 

HCA Healthcare, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-11239

27-3865930

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

One Park Plaza

 

Nashville, Tennessee

 

37203

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (615) 344-9551

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

HCA

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02. Results of Operations and Financial Condition.

On October 24, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1.

Item 7.01. Regulation FD Disclosure.

On October 24, 2025, the Company issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1.

Item 8.01. Other Events.

On October 24, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on December 29, 2025 to stockholders of record at the close of business on December 15, 2025.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit 99.1

Press Release, dated October 24, 2025

Exhibit 104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

HCA HEALTHCARE, INC.

 

 

 

 

Date:

October 24, 2025

By:

/s/ Michael A. Marks

 

 

 

Michael A. Marks
Executive Vice President and Chief Financial Officer

 


FAQ

What did HCA (HCA) announce in this 8-K?

The company issued a press release with Q3 2025 results and declared a quarterly cash dividend.

How much is HCA’s quarterly dividend?

The Board declared a $0.72 per-share cash dividend on common stock.

When is the HCA dividend record date?

Shareholders of record at the close of business on December 15, 2025 will receive the dividend.

When will HCA pay the dividend?

The dividend will be paid on December 29, 2025.

Where can I find HCA’s Q3 2025 results details?

They are provided in the press release attached as Exhibit 99.1.

What is HCA’s trading symbol and exchange?

HCA’s common stock trades on the New York Stock Exchange under the symbol HCA.
Hca Healthcare Inc

NYSE:HCA

HCA Rankings

HCA Latest News

HCA Latest SEC Filings

HCA Stock Data

101.09B
162.42M
30.82%
63.17%
1.83%
Medical Care Facilities
Services-general Medical & Surgical Hospitals, Nec
Link
United States
NASHVILLE